TR201620485A2 - Butami̇rat pasti̇l formülasyonu ve üreti̇m yöntemi̇ - Google Patents
Butami̇rat pasti̇l formülasyonu ve üreti̇m yöntemi̇ Download PDFInfo
- Publication number
- TR201620485A2 TR201620485A2 TR2016/20485A TR201620485A TR201620485A2 TR 201620485 A2 TR201620485 A2 TR 201620485A2 TR 2016/20485 A TR2016/20485 A TR 2016/20485A TR 201620485 A TR201620485 A TR 201620485A TR 201620485 A2 TR201620485 A2 TR 201620485A2
- Authority
- TR
- Turkey
- Prior art keywords
- butamirate
- pastil
- formulation
- production method
- cough
- Prior art date
Links
- DDVUMDPCZWBYRA-UHFFFAOYSA-N butamirate Chemical compound CCN(CC)CCOCCOC(=O)C(CC)C1=CC=CC=C1 DDVUMDPCZWBYRA-UHFFFAOYSA-N 0.000 title abstract 2
- 229960004902 butamirate Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- 206010011224 Cough Diseases 0.000 abstract 2
- 238000001356 surgical procedure Methods 0.000 abstract 2
- 201000005702 Pertussis Diseases 0.000 abstract 1
- 238000013276 bronchoscopy Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 239000007937 lozenge Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Mevcut buluş, çeşitli nedenlerden dolayı oluşan öksürük, ameliyatta veya bronkoskopide ameliyat öncesi ve sonrasında öksürük ve boğmaca tedavisinde ilaç olarak kullanılan butamirat veya onun farmasötik açıdan kabul edilebilir bir tuzunu ve en az bir tane farmasötik olarak kabul edilebilir yardımcı madde içeren stabil, homojen ve hoş bir tada sahip pastil formunda farmasötik bileşim ve bu bileşimin üretim yöntemleri ile ilgilidir.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2016/20485A TR201620485A2 (tr) | 2016-12-31 | 2016-12-31 | Butami̇rat pasti̇l formülasyonu ve üreti̇m yöntemi̇ |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TR2016/20485A TR201620485A2 (tr) | 2016-12-31 | 2016-12-31 | Butami̇rat pasti̇l formülasyonu ve üreti̇m yöntemi̇ |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR201620485A2 true TR201620485A2 (tr) | 2018-07-23 |
Family
ID=64606526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2016/20485A TR201620485A2 (tr) | 2016-12-31 | 2016-12-31 | Butami̇rat pasti̇l formülasyonu ve üreti̇m yöntemi̇ |
Country Status (1)
| Country | Link |
|---|---|
| TR (1) | TR201620485A2 (tr) |
-
2016
- 2016-12-31 TR TR2016/20485A patent/TR201620485A2/tr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1125772T1 (el) | Μακροκυκλικες ενωσεις για τη θεραπευτικη αντιμετωπιση νοσων | |
| MX2021004639A (es) | Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para uso en el tratamiento de tumores solidos. | |
| MX387322B (es) | Formulaciones de inhibidor de demetilasa 1 especifica para lisina (lsd1). | |
| ZA202103587B (en) | Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as atr kinase inhibitors | |
| MX2023006541A (es) | Formulaciones de dosis fija. | |
| MX390014B (es) | Compuestos de dinucleótidos cíclicos y métodos de uso. | |
| PH12017500281A1 (en) | Pyrrolopyrimidine compounds used as tlr7 agonist | |
| JOP20170135A1 (ar) | مركبات ديازاسبيروألكيل مثيل-إندول | |
| MX379155B (es) | Compuestos que inhiben la proteína mcl-1. | |
| JOP20190191A1 (ar) | وحدات شجرية علاجية | |
| MX2017014994A (es) | Formulacion solida oral que contiene irinotecano y metodo de preparacion de la misma. | |
| CL2019002218A1 (es) | Formulaciones de combinación triple y métodos para tratar o reducir el riesgo de enfermedad cardiovascular. | |
| PH12018502089A1 (en) | Pharmaceutical composition of dapagliflozin | |
| MX392182B (es) | Combinaciones de dosis fija y formulaciones que comprenden ácido 8-hidroxi-2,2,14,14 tetrametilpentadecanodioico (etc1002) y ezetimiba y métodos para tratar o reducir el riesgo de enfermedad cardiovascular. | |
| EP4477265A3 (en) | Methods of treating new-onset plaque type psoriasis using il-17 antagonists | |
| MX377919B (es) | Composiciones farmaceuticas solidas que comprenden derivados de biopterina y usos de tales composiciones. | |
| MX387731B (es) | Composiciones farmacéuticas orales de mesalazina. | |
| MX385518B (es) | FORMULACIÓN QUE TIENE CARACTERÍSTICAS MEJORADAS DE LIBERACIÓN DE FÁRMACOS pH DEPENDIENTES, QUE CONTIENEN ESOMEPRAZOL O UNA DE SUS SALES FARMACÉUTICAS ACEPTABLE. | |
| MX379253B (es) | Formulaciones de oximetazolina estabilizadas y sus usos. | |
| JOP20170148A1 (ar) | مثبطات Wnt لعلاج التليف | |
| EA201991286A1 (ru) | Твердая фармацевтическая композиция для перорального применения, содержащая тенофовир и эмтрицитабин | |
| MX362885B (es) | Pastilla para tratar garganta irritada, ronquera y tos seca asociada, y enfermedades inflamatorias de la cavidad oral y faringea. | |
| BR112018071363A2 (pt) | composições farmacêuticas orais de nicotinamida | |
| UA116499C2 (uk) | (r)-пірліндол та його фармацевтично прийнятні солі для застосування в медицині | |
| BR112019017314A2 (pt) | composições farmacêuticas para terapia de combinação |